AI in Rare Diseases

Evaluate how AI-driven DNA screening tools can improve early diagnosis for rare diseases, including dataset biases, privacy, interpretability, accessibility, and global health equity. Compare outputs to traditional diagnostic approaches, and design a deployment plan for a public health system to integrate such tools while ensuring ethical use.